2023年4月13日

分享這篇文章提供的新聞分享這篇文章Limbix組裝不同的供應商團隊,父母,和病人訪問國會山和冠軍數字療法對青少年心理健康的重要性。2023年4月13日,舊金山——Limbix數字療法(DTx)開發人員對於青少年心理健康,導致國會山倡導努力提高認識當前青年的心理健康危機和數字治療方案的重要性。兩天期間,Limbix與十二advisors董事、記者,代表和參謀長:Kripa Sreepada(參議院財政),瑞安長麥卡錫(揚聲器),斯圖爾特•波特曼(參議院財政),艾琳Doty(眾議員Ruiz),莉莉沃爾什(參議員科寧),莎拉·施密特(參議員圖恩),眾議員DeSaulnier丹尼爾Zawitoski(眾議員Peters)、馬克斯•塞弗特(Merkley參議員)尼基奧卡河(衰老委員會/森。的供應商參加全國參與多樣化的社區和有實際經驗提供SparkRx, Limbix數字治療青少年抑鬱症。團隊也在西蒙的陪同下,一個15歲的青少年用戶SparkRx,和她的父親,特裏,提供一個有形的例子DTx對青年心理健康產生積極的影響。”的感覺知道我幫助其他青少年通過談論自己的心理健康是非常有益的經驗,”西蒙說,“這是一個改變人生的體驗。”The biggest challenge our youth face post pandemic, is the limitations in mental health resources -- Father of SparkRx User Depression is the most common mental health disorder among adolescents in the United States. Feelings of persistent sadness, hopelessness, suicidal thoughts, and suicidal behaviors increased by roughly 40% among young people in the 10 years leading up to the pandemic, per the CDC's Youth Risk Behavior Surveillance System. "As a parent and a member of the academic community, the biggest challenge our youth face following the pandemic is the limitations in mental health resources," Terry, who is also a professional/college athletic administrator, explains, "Digital therapeutics provide a viable and universal solution to addressing the needs of mental health within our community." Through evidence-based treatment options on accessible electronic devices, digital therapeutics can improve outcomes for young people with mental health challenges. By amplifying the voice of adolescents struggling with mental health and the providers caring for them, Limbix's advocacy efforts on Capitol Hill have shed light on the need for expanded access to digital treatment options, offering a path forward for lawmakers to better aid the American youth. "The team is encouraged by the receptiveness of lawmakers and their staff to our message," says Dr. Benjamin Alouf, Chief Medical Officer at Limbix. "We're excited that our efforts will lead to greater awareness and access to digital therapeutics for young people in need." About Limbix Health, Inc Limbix is on a mission to make mental health treatment accessible to young people who need it the most when they need it the most. Limbix's diverse team of clinicians, product designers, researchers, and engineers are uniquely suited for developing mental health technology, as they understand the value of combining clinical expertise with technological innovation. The team focuses on giving young people access to affordable, effective behavioral health care by building safe and evidence-based treatment options that providers can offer their patients. Through extensive research, Limbix built their first digital therapeutic, SparkRx , that delivers CBT-based treatment for teen depression directly to users' smartphones. Socials SparkRx Safety Information SparkRx is a digital therapeutic intended to provide a neurobehavioral intervention (Cognitive Behavioral Therapy - Behavioral Activation) in patients 13 to 22 years of age as adjunct treatment for symptoms of depression. SparkRx has not been cleared or approved by the U.S. Food and Drug Administration. SparkRx is not for emergency use. SparkRx is not meant to be used as treatment without supervision of a health care provider. SparkRx is not meant to be a substitution for any treatment or medication. SparkRx does not address concerns of active suicidal ideation with intent. SparkRx is not intended for the prevention of suicide attempts or self-harm behaviors. For more safety information about SparkRx, visit sparkrx.com to learn more. Complete SparkRx safety information can be found here . SOURCE Limbix